Conceivably, dissecting the molecular relationship between FSH and ApoE4 and their roles in activating C/EBPβ/δ-secretase signaling pathway, selectively triggering AD pathogenesis in female, will provide significant insight into the molecular mechanism and potential drug targets for interfering the devastating neurodegenerative disease. The gene discussed is APOE; the disease is Alzheimer disease.